Effect of mifepristone (25 mg) in treatment of uterine myoma in perimenopausal woman

OBJECTIVES: To evaluate the effect of Mifepristone (25 mg) on symptomatic myoma in perimenopausal women. STUDY DESIGN: Open label clinical trial. MATERIALS AND METHODS: Ninety three perimenopausal women of age 35-50 years having symptomatic myoma were selected from Gynecology OPD and given 25 mg Mif...

Descripción completa

Detalles Bibliográficos
Autores principales: Seth, Shikha, Goel, Neeru, Singh, Ekta, Mathur, A. S., Gupta, Garima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702060/
https://www.ncbi.nlm.nih.gov/pubmed/23833529
http://dx.doi.org/10.4103/0976-7800.109630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702060/
https://www.ncbi.nlm.nih.gov/pubmed/23833529
http://dx.doi.org/10.4103/0976-7800.109630

Ejemplares similares